Biotech
Ambros Therapeutics Merges to Advance Rare Disease Drug
Ambros Therapeutics now joins with Werewolf to bring a new rare disease medicine closer to patients in need.
A big change happened for a company called Werewolf Therapeutics. It has now joined with Ambros Therapeutics. This new company, Ambros, will focus on a special medicine for a rare disease.
Ambros Therapeutics also raised a lot of money, $150 million. This money helps Ambros move its lead drug forward. The drug helps people with a rare illness. The company wants to get the drug approved for use.
This move helps Ambros get its important medicine through the final testing steps. Patients with this rare disease may soon have a new treatment option. This news brings hope to many families.
Source: FierceBiotech
#Biotech#Merger#Rare Disease
